Vice President, Business Development and Alliance Management
Xaira Therapeutics
Vice President, Business Development and Alliance Management
Xaira Therapeutics
AI-powered protein design for therapeutics
About Xaira Therapeutics
Xaira is an innovative biotech startup focused on leveraging AI to transform drug discovery and development. The company is leading the development of generative AI models to design protein and antibody therapeutics, enabling the creation of medicines against historically hard-to-drug molecular targets. It is also developing foundation models for biology and disease to enable better target elucidation and patient stratification. Collectively, these technologies aim to continually enable the identification of novel therapies and to improve success in drug development. Xaira is headquartered in the San Francisco Bay Area, Seattle, and London.
The Role
Reporting to the Senior Vice President, Business Development and Operations, the Vice President, Business Development will lead the identification, development, negotiation, and execution of major strategic transactions that expand the reach and value of Xaira’s platform.
This role will focus primarily on originating and executing significant AI platform, technology, and multi-program partnerships. Unlike a traditional biotechnology business development role centered on individual asset licensing, this leader will develop complex partnerships built around Xaira’s differentiated scientific and technical capabilities, with the potential to span multiple platform technologies, programs, disease areas, and stages of research and development.
The Vice President will work closely with the SVP of Business Development and Operations, executive leadership, scientific and technical leaders, and legal and finance partners to shape partnering strategy, identify high-value opportunities, and lead transactions from initial engagement through negotiation, execution, and transition to alliance management.
The ideal candidate combines strong transaction leadership with the ability to understand differentiated science and technology, translate Xaira’s AI and drug development capabilities into strategic and commercial value, and develop creative deal structures with pharmaceutical, biotechnology, technology, and other strategic partners.
Key Responsibilities
Business Development Strategy
Deal Origination and Partner Engagement
Transaction Leadership
Cross-Functional Leadership
Alliance Management
Platform Positioning and Market Development
Qualifications
Core Competencies
Compensation
We offer a competitive compensation and benefits package, seeking to provide an open, flexible, and friendly work environment to empower employees and provide them with a platform to develop their long-term careers. A Summary of Benefits is available for all applicants. We offer a competitive package that includes base salary, bonus, and equity. The base pay range for this position is expected to be $250,000 - $325,000 annually; however, the base pay offered will vary depending on the market, job-related knowledge, skills and capabilities, and experience.
Xaira Therapeutics an equal-opportunity employer. We believe that our strength is in our differences. Our goal to build a diverse and inclusive team began on day one, and it will never end.
TO ALL RECRUITMENT AGENCIES: Xaira Therapeutics does not accept agency resumes. Please do not forward resumes to our jobs alias or employees. Xaira Therapeutics is not responsible for any fees related to unsolicited resumes.
AI-powered protein design for therapeutics
Xaira Therapeutics uses artificial intelligence to transform drug discovery and development. It builds a pipeline of protein- and antibody-based therapeutics by combining generative AI models from the IPD lab (notably RFdiffusion and RFantibody) with large, multidimensional biological data. The company designs novel proteins and antibodies from scratch to target difficult, previously undruggable biology, then validates and evolves these molecules through iterative data generation that improves its biological foundation models. Unlike many entrants that offer research services, Xaira aims to own and advance its own therapeutic pipeline across multiple modalities, rather than solely providing platforms. The goal is to deliver effective new medicines faster and with a lower chance of failure by integrating AI-driven design, expansive data, and expert leadership.
Explore more opportunities at Xaira Therapeutics